Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

byBenzinga Newsdesk

October 24, 2022

1 minute read

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

Analyst Ratings

What 4 Analyst Ratings Have To Say About Acushnet Hldgs

By Benzinga Insights

August 21, 8:00 AM

Analysts have provided the following ratings for Acushnet Hldgs (NYSE:GOLF) within the last quarter: Bullish Somewhat Bullish Indifferent…

GOLF

GE HealthCare Receives FDA Clearance For Portrait VSM, Building In Its Growing Ecosystem Of Connected Patient Monitoring Solutions

By Benzinga Newsdesk

April 29, 9:13 AM

The portable vital signs monitor (VSM) adds to GE HealthCare's growing Portrait Ecosystem to help clinicians make timely treatment decisions and detect patient deterioration earlier with a streamlined spot check

GEHC

Needham Reiterates Buy on MagnaChip Semiconductor, Maintains $13 Price Target

By Benzinga Newsdesk

February 17, 10:32 AM

Needham analyst Rajvindra Gill reiterates MagnaChip Semiconductor (NYSE:MX) with a Buy and maintains $13 price target.

Analyst Ratings

7 Analysts Have This to Say About Invesco

By Benzinga Insights

July 28, 12:21 PM

Within the last quarter, Invesco (NYSE:IVZ) has observed the following analyst ratings:

IVZ

SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

Related Posts

What 4 Analyst Ratings Have To Say About Acushnet Hldgs

GE HealthCare Receives FDA Clearance For Portrait VSM, Building In Its Growing Ecosystem Of Connected Patient Monitoring Solutions

Needham Reiterates Buy on MagnaChip Semiconductor, Maintains $13 Price Target

7 Analysts Have This to Say About Invesco